A 60-year-old woman with type 2 diabetes and obesity is found to have elevated liver enzymes and ultrasound evidence of hepatic steatosis. Viral serology is negative and she drinks minimal alcohol. What is the most important first-line management strategy for her non-alcoholic fatty liver disease (NAFLD)?